HCSA, MAS and ASAS Rules for Singapore Web Copy

There is a provision in Singapore law that makes a marketing agency personally liable for what it publishes on a client's website. It is Regulation 18(4) of the Healthcare Services (Advertisement) Regulations 2021, and it carries a fine of up to twenty thousand Singapore dollars, imprisonment of up to twelve months, or both, plus a further fine of up to one thousand dollars for every day a continuing offence persists after conviction.

Most agency content about Singapore healthcare marketing does not mention it. Most agency content about Singapore healthcare marketing also states that patient testimonials are absolutely prohibited, which is not what the regulation says, and attaches a single twenty thousand dollar figure to every kind of breach, which is also not what the regulation says.

We read the text. This article covers what three regulatory frameworks actually require of page copy in Singapore: the healthcare advertising regulations, the Monetary Authority of Singapore guidelines that took effect on 25 March 2026, and the general advertising code administered by the Advertising Standards Authority of Singapore. It is regulatory orientation and not legal advice, and the provisions applying to your specific licence need your own counsel.

Healthcare, where the rules reach furthest into the copy

The governing instrument is the Healthcare Services (Advertisement) Regulations 2021, made under section 57 of the Healthcare Services Act 2020, in operation since 3 January 2022 and amended by S 404/2023. It replaced the older private hospitals and medical clinics advertising framework.

Start with scope, because scope catches people first. Regulation 3(2) provides that the regulations apply to an advertisement with a Singapore link, which exists where the advertisement is accessible by a person physically present in Singapore, or is addressed to persons the advertiser knows or believes to be physically in Singapore. Regulation 3(3) adds that in determining accessibility it is assumed the person will not falsify or conceal their identity or location.

Read plainly, that means essentially any publicly reachable page for a Singapore clinic is caught. Not just paid ads. The service pages. The condition explainers. The doctor profiles. A blog post published three years ago and forgotten.

The content rules in Regulation 5

Regulation 5(1) is the provision that shapes copywriting. Six parts of it matter directly to search work.

Information must be factually accurate and capable of being substantiated, and must not be exaggerated, false, misleading or deceptive. The advertisement must not be offensive, ostentatious or in bad taste, nor undermine the honour and dignity of any healthcare profession. It must not imply that the licensee can obtain results other licensees cannot achieve, create an unjustified expectation, compare the quality of its service against another licensee's, or deprecate another licensee's service.

Then two that catch conventional marketing instinct squarely. Regulation 5(1)(d) prohibits any photograph, picture, video or film showing an individual's appearance or a feature of it before and after, or only after, receiving treatment. The prohibition applies whether or not the image creates an unjustified expectation, and whether or not the images relating to the same treatment sit in one advertisement or across several. Splitting a before image and an after image across two posts does not solve it. Regulation 5(2) permits showing such material to a patient during that patient's consultation, and that is the entire exception.

Regulation 5(1)(e) prohibits any laudatory statement, including a statement of prominence or uniqueness, or superlative, used to describe the service. This is broader than the usual reading. Best and leading are obviously out. So are the only clinic in Singapore that, our unique approach, and number one, because prominence and uniqueness are named in the provision itself.

And Regulation 5(1)(g) prohibits providing information in a manner amounting to soliciting or encouraging use of the service, which is a genuinely difficult constraint for anyone whose job description is conversion optimisation.

The testimonial rule, stated properly

Here is where the market gets it wrong, and it matters because a clinic acting on the wrong version either breaks the rule or throws away something it is allowed to keep.

Regulation 5(1)(f) prohibits reviews, testimonials and endorsements, but the provision opens with the words except as provided in regulation 14. Regulation 14(2) then permits a licensee to display an applicable review, testimonial or endorsement inside its approved premises, or on its own website or social media account, and only where the material was given by that person directly to the licensee and is not reproduced by the licensee or an authorised person.

Regulation 14(5) defines applicable narrowly. It must come from an individual who is or has been a patient, or is the next of kin or carer of a patient. It must not have been given in return for money, other valuable consideration or any other benefit. And it must not have been substantively modified before publication.

So the operational rules are specific. A review a patient sent your clinic directly, unpaid and unedited, may appear on your own site. A Google review copied or screenshotted onto your site may not, because that is reproduction. A paid influencer endorsement is out. An edited quote is out. Regulation 14(2A) removes the exception entirely for assisted reproduction services. And practitioners are separately bound by their professional code, which is stricter again on testimonials over which the doctor has content control, so clinical staff should treat this cautiously rather than optimistically.

The penalty structure, which is tiered and not flat

Agency content commonly states a twenty thousand dollar fine for HCSA advertising breaches. The regulation is more structured than that, and the distinction matters because the provisions most often touched by page copy are not the ones carrying that figure.

Regulation 18(3) states the twenty thousand dollar figure directly, for a licensee contravening Regulations 9(2) or (3), 10, 11, 13(1), 14(1), or 16(1) or (3). Regulation 18(4) applies the same figure to an authorised person contravening Regulations 13(2), 14(1) or 16(1) or (3). Regulations 18(5) through (7) apply it again to failures to rectify and to non-compliance with an order from the Director-General.

But Regulation 18(1) handles the content rules differently. A licensee contravening Regulation 5(1), meaning the superlatives, the before and after imagery, the comparisons and the solicitation rules, is guilty of an offence under section 31(3) of the Healthcare Services Act 2020 and is punished in accordance with that section. The figure lives in the Act, not in the Regulations.

We did not verify the section 31(3) figure to primary source, so we are not going to state one. That is deliberate. Quoting a number we have not checked would be exactly the failure this article is about.

Framework	Regulator	What it constrains in page copy	Does it reach the agency?
HCSA Advertisement Regulations 2021	Ministry of Health	Superlatives, prominence and uniqueness claims, before and after imagery, comparisons, testimonials, promotional programmes, outbound links	Yes, directly, under Regulation 18(4)
Guidelines on Standards of Conduct for Digital Advertising Activities, FSG-03	Monetary Authority of Singapore	Balance and fairness of financial advertising, approval workflow, who may publish and on whose authority	Yes, digital marketers are within scope
Health Products Act	Health Sciences Authority	Therapeutic claims, false or misleading health product advertising, promotion of prescription-only products to the public	Applies to the person advertising
Singapore Code of Advertising Practice	Advertising Standards Authority of Singapore	Truthfulness and substantiation of claims, comparative advertising, disclosure of sponsored and native content	Advertisers and agencies both expected to hold evidence

Financial services, and what changed on 25 March 2026

The Monetary Authority of Singapore published the Guidelines on Standards of Conduct for Digital Advertising Activities, Guideline No. FSG-03, on 25 September 2025. The text states that the guidelines take effect on 25 March 2026. They apply to all financial institutions and to their digital marketers who advertise financial products and services through digital media, including social media platforms.

Digital marketers means agencies. Three expectations in the guidelines change how a search engagement has to run.

Board and senior management remain accountable for digital advertising activities, including activities outsourced to third parties. Financial institutions are expected to maintain a framework for assessing and selecting digital marketers, with selection criteria including relevant qualifications. And institutions are expected to keep marketers informed of updates to practices and regulatory requirements through regular training and, for external marketers, through formal agreements setting out mandatory rules and compliance obligations. The guidelines note that institutions may consider contractual terms prohibiting marketers from inserting additional content the institution has not approved.

The practical translation is that an agency publishing financial content on its own judgement is no longer a workable operating model in this vertical. You need documented approval gates, version control, and a record of who signed off on what. MAS also issued a paired guide for online content creators alongside the guidelines, and advisory letters to five content creators over content that may have amounted to unlicensed financial advice, which is a reasonable signal about enforcement appetite.

Health products, and the figure that circulates wrongly

Separately from the healthcare services framework, the Health Products Act governs advertising of health products, administered by the Health Sciences Authority. The Ministry of Health has stated that false and misleading advertisements under the Health Products Act attract a maximum penalty of twenty thousand dollars, imprisonment of up to twelve months, or both.

A different figure circulates in AI-generated and agency content: five thousand dollars with twelve months. It does not exist. It appears to be two statutes spliced together, because the five thousand dollar maximum belonged to the Medicines Act framework, and the imprisonment term attached to that maximum was up to two years rather than twelve months. Neither statute contains the combination.

We flag it specifically because it is the kind of error that survives repetition. A number that sounds plausible, attached to a real statute, in a sentence nobody checks.

Beyond the penalty figure, three Health Sciences Authority positions bear directly on content work. Advertisements for medical devices must be truthful, not misleading, and supported where a claim requires scientific substantiation. Consumer-directed promotion of prescription-only medicines is prohibited, as is promotion of certain devices intended for professional use only, which means the brand names and active ingredients of prescription products cannot be targeted on a public landing page. And for medicinal and traditional health products, a permit may be required before public advertising depending on the product and the claim type.

The point that catches search teams hardest is the last one hiding inside all three. Content produced as an explainer is not automatically exempt because it was written to inform. The Authority's definitions can capture direct or indirect promotion, so a page framed as education that steers a reader toward a specific prescription product is doing the thing the rule prohibits, regardless of the heading above it. If your content strategy in this category depends on informational pages carrying commercial weight, that assumption needs testing with counsel before the pages get written rather than after.

General advertising, which applies to everyone else

The Singapore Code of Advertising Practice, administered by the Advertising Standards Authority of Singapore under the Consumers Association of Singapore, requires advertisements to be legal, decent, honest and truthful, and it applies across formats including digital. It expects objectively ascertainable claims and comparisons to be substantiated, and expects advertisers and agencies to hold supporting evidence available for production.

Two points are easy to miss. Ranking well organically does not exempt a page from advertising rules, because a service page optimised for search still functions as a promotional communication. And the code includes specific disclosure requirements for sponsored and native content, set out in the Authority's guidance notes for interactive marketing communication and social media, with format-specific rules covering images, video and audio. That reaches guest posts, paid placements and influencer-adjacent content used for link acquisition, so if part of your off-page programme involves paid placement, disclosure is a code question and not only an editorial preference.

It is worth being concrete about which claim types the substantiation expectation actually bites on, because teams tend to assume it applies only to obvious puffery. In practice it reaches superlatives such as best, leading, largest and number one; performance comparisons against named or implied competitors; health outcome claims; financial return claims; sustainability and environmental claims; customer-volume and market-share claims; awards and certifications; before-and-after claims; and testimonials presented as though they describe a typical outcome. That last one is the most commonly missed, because a genuine and accurate testimonial can still breach the expectation if the page implies the result it describes is what most customers get.

The operational consequence is a claims register rather than a proofreading pass. Every claim in that list needs its substantiating evidence identified before publication and retrievable afterwards, because both advertisers and their agencies are expected to hold supporting evidence available for production. Evidence you cannot find on request is functionally the same as evidence you never had.

What this costs you in ranking terms, honestly

Compliance narrows the copywriting space. Pretending otherwise is not useful, so here is the trade-off as we see it.

You lose the easy conversion levers. No superlatives, no dramatic imagery, no reproduced review wall, no urgency built on discount framing. What remains is narrower and, in a search context, frequently stronger: factually accurate condition and procedure pages that answer what people actually search, practitioner profiles in a neutral register, structured data that helps engines read the site, a properly maintained business profile, and a review process that stays inside Regulation 14.

That set overlaps substantially with what performs well anyway, because substantiated specificity ranks better than adjectives in almost every category. The genuine cost is speed. Every page carries an approval step, so a content programme that ships twelve pages a month in an unregulated vertical will ship fewer here, and the plan should say so from the start rather than discovering it in month three.

We found no study measuring compliance failure rates for search content in Singapore's regulated verticals, and no study measuring the ranking cost of compliant versus non-compliant copy. Both would be useful. Neither exists as far as we can tell, so treat the trade-off above as reasoning rather than as a measured finding.

How we run it

For regulated verticals we scope the approval workflow before the keyword research, not after, because keyword opportunity in these categories arrives attached to compliance risk and the two decisions cannot be sequenced separately. That is how our SEO service for Singapore handles healthcare and financial services engagements, and it is also why the vocabulary work described in our piece on the Singapore keyword vocabulary arrives with a compliance column attached in these categories.

One thing we do not do is treat generative engine visibility as a compliance shortcut. The same substantiation rules apply to content written for AI citation, and citation measurement is a separate discipline with separate instrumentation, which is why it sits in our GEO service for Singapore rather than inside a ranking report.

---

Frequently Asked Questions

Can a Singapore clinic do SEO at all under the HCSA rules?

Yes. The internet is a permitted advertising medium and search is a legitimate channel. What is constrained is the content, not the channel. Factually accurate condition and treatment information, practitioner profiles in a neutral register, structured data and a maintained business profile all sit inside the permitted space. What you lose is superlative language, before and after imagery, reproduced reviews and discount-driven urgency.

Are patient testimonials completely banned in Singapore?

No, and the flat prohibition often quoted is inaccurate. Regulation 14(2) permits an applicable review or testimonial on the licensee's own website, social media account or premises, where it was given by that person directly to the licensee and is not reproduced. Regulation 14(5) requires it to come from a patient or their next of kin or carer, to be unpaid, and not to have been substantively modified. Copying or screenshotting a Google review onto your site fails the reproduction test. Assisted reproduction services are excluded from the exception entirely under Regulation 14(2A).

Is the fine for HCSA advertising breaches really twenty thousand dollars?

For some provisions, yes, but not for all of them. Regulation 18(3) and 18(4) state a fine of up to twenty thousand dollars, imprisonment of up to twelve months, or both, plus up to one thousand dollars per day for a continuing offence, for a specific list including Regulations 13, 14(1) and 16. Contraventions of the Regulation 5(1) content rules, meaning superlatives, imagery and comparisons, are handled under Regulation 18(1), which routes to section 31(3) of the Healthcare Services Act 2020 instead. We have not verified that figure to primary source, so we do not state one.

Can my marketing agency be held liable, or only my clinic?

Both. Regulation 2 defines an authorised person as someone acting on the licensee's authority in advertising a licensable healthcare service, which covers an agency managing your site and content. Regulation 18(4) makes an authorised person who contravenes Regulations 13(2), 14(1) or 16(1) or (3) directly liable to the same penalty range. Any agency working in this vertical should already know this, and the fact that most agency content omits it is worth noting when you evaluate providers.

Do the rules really cover outbound links on our own site?

Yes, and this catches people. Regulation 16(1) prohibits a licensee from publishing a link to another site containing the prohibited content types, such as unsubstantiated claims, before and after imagery or superlatives. Regulation 16(2) provides a defence where the licensee did not know and had no reason to believe the destination was non-compliant at the time of linking. Regulation 16(3) requires immediate removal once aware. So link governance becomes a recurring audit with an owner, because destination sites change without notifying you.

We are a financial institution. What exactly changed on 25 March 2026?

That is the effective date of the MAS Guidelines on Standards of Conduct for Digital Advertising Activities, Guideline No. FSG-03, published on 25 September 2025. They apply to financial institutions and their digital marketers, including agencies. Board and senior management remain accountable even for outsourced advertising, institutions are expected to maintain a framework for assessing and selecting digital marketers, and formal agreements setting out mandatory rules and compliance obligations are expected for external marketers. Contractual terms preventing a marketer from inserting unapproved content are explicitly contemplated.

Does ranking organically exempt a page from advertising rules?

No. A service page optimised for organic search still functions as a promotional communication, and the Singapore Code of Advertising Practice applies across formats including digital. It requires claims to be truthful and substantiated, and it expects both advertisers and agencies to hold supporting evidence available. There is no organic exemption, and the same logic applies to content written primarily for machine extraction.

Does compliance make it impossible to compete on search?

It makes it slower, not impossible. The permitted space, meaning substantiated specificity, clear structure, neutral practitioner credentials and genuine subject depth, overlaps heavily with what ranks well in any category. The real cost is throughput, because every page carries an approval step. Plan for a lower publishing rate from the outset rather than discovering it mid-programme. We found no study measuring the ranking cost of compliant versus non-compliant copy in Singapore, so treat that as reasoning rather than a measured result.

What about health products and supplements rather than clinical services?

Those fall under the Health Products Act administered by the Health Sciences Authority, which is a separate framework from the healthcare services advertising regulations. The Ministry of Health has stated that false and misleading advertisements under that Act attract a maximum penalty of twenty thousand dollars, imprisonment of up to twelve months, or both. Be careful with a five thousand dollar figure circulating alongside a twelve-month term. That combination appears in neither statute and looks like two different frameworks merged.

---